Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Commitment (own venture)

Rules 1.1.0 · as of 14 Sep 2026

Quote

Commitment (own venture)

“especially before @ataibeckley's anticipated Phase 2b FDA meeting minutes for BPL-003 and Phase 2 EMP-01 (R-MDMA) data will be released this first quarter of 2026... Gonna be a busy and exciting quarter for the AtaiBeckley team!”
· Christian Angermayer on X: view on the psychedelic sector before Q1 2026 catalysts · tweet

Angermayer says the BPL-003 end-of-Phase-2b FDA meeting minutes and the EMP-01 (R-MDMA) Phase 2 data will both be released in the first quarter of 2026.

The forecaster's own organization can make the outcome happen by its own decision: clinic openings, product launches, hires, trial starts, filings by their own company. Listed in the commitments table, never scored.